Quantcast

Latest Management of cancer Stories

2014-06-01 08:20:41

NEW YORK, June 1, 2014 /PRNewswire/ -- The Cancer Research Institute (CRI) is proud to announce the launch of a first-of-its-kind website devoted to cancer immunotherapy, also called immuno-oncology, designed specifically for cancer patients and their caregivers, TheAnswerToCancer.org. http://photos.prnewswire.com/prnvar/20140530/92827 "As major advances in cancer immunotherapy begin to alter the landscape of cancer treatment, patients facing a cancer diagnosis need to be aware of...

2014-06-01 08:20:22

Large International Cohort of 17 GI Cancer Types Confirms the Unique Clinical Utility of Caris Molecular Intelligence(TM) CHICAGO, June 1, 2014 /PRNewswire/ -- Caris Life Sciences, a leading biosciences company focused on fulfilling the promise of precision medicine, announced today the presentation of clinical data at the 50th Annual Meeting of ASCO in which molecular profiling identified numerous potential drug options in patients with various types of gastrointestinal (GI) cancer. Among...

2014-05-31 08:21:17

Data Support Adoption of Stable Disease as Response Criterion, Raise Intriguing Hypotheses about Sequential Therapy and Utility of IL-2 as Salvage Option CHICAGO, May 31, 2014 /PRNewswire/ -- Prometheus Laboratories Inc. announced today that data from the PROCLAIM(SM) national patient registry retrospective cohort document an improvement in median overall survival (OS) in patients with metastatic melanoma who were treated with high-dose Proleukin(®) (aldesleukin) as compared to...

2014-05-29 08:29:37

New Data Presented at ASCO® Annual Meeting Suggest that Genomic Health's Oncotype DX Test May Help Identify Patients That Have the Greatest Opportunity to Benefit from Extended Hormonal Therapy REDWOOD CITY, Calif., May 29, 2014 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced results of a large, positive study that confirmed that the Oncotype DX® test results for Recurrence Score® and quantitative estrogen-receptor (ER) predict late distant recurrence risk in...

2014-05-28 04:24:21

LONDON and TORONTO, May 28, 2014 /PRNewswire/ -- ThioBridge(TM) linker to attach cytotoxic payloads to alpha fetoprotein PolyTherics Limited ("PolyTherics"), an Abzena company that provides technologies and services to enable the development of better biopharmaceuticals, today announced a collaboration with Alpha Cancer Technologies Inc. ("ACT"), a Canadian company with a targeted drug delivery platform based on alpha fetoprotein ("AFP"). PolyTherics will produce...

2014-05-27 12:32:22

SEATTLE, May 27, 2014 /PRNewswire/ -- Adaptive Biotechnologies, the pioneer of Next Generation Sequencing of the adaptive immune system, and its collaborators will present data supporting the clinical application of immunosequencing in diagnosing and monitoring T cell lymphomas at the 2014 Annual Meeting of the American Society of Clinical Oncology. Data will also be presented demonstrating how immunosequencing can be used to elucidate the activity of immunotherapeutic combination...

2014-05-20 23:17:41

Elite cancer care specialists in Turkey are providing the latest technology and the most innovative, affordable therapies to increase the chances of a cure. Surgeons, radiologists, pathologists, radiation oncologists, and cancer care specialists at VisitandCare.com are working together to implement advanced treatment options to foreign cancer patients. Los Angeles, CA (PRWEB) May 20, 2014 A close collaboration between oncologists in Turkey and expert scientists is generating...

2014-05-20 08:31:42

CALGARY, May 20, 2014 /PRNewswire/ - Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC) (NASDAQ:ONCY) today announced that an abstract detailing early results from translational study looking at the intravenous administration of REOLYSIN(®) to patients with primary or metastatic brain tumors is now available on the ASCO Annual Meeting abstract website at http://abstracts.asco.org. The conference is being held from May 30(th) to June 3(rd), 2014 in Chicago, Illinois. "Treatment...

2014-05-19 23:02:53

Transparency Market Research Report Added "Adjuvants Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast 2012 - 2018" to its database. Browse Full Report: http://www.transparencymarketresearch.com/adjuvants-market.html. Albany, New York, USA (PRWEB) May 19, 2014 Adjuvant oncology treatment comprises of a class of cancer therapeutics which is followed after primary cancer treatment, to minimize the risk of reoccurrence of cancer. The major forms of...

Ultra-sensitive Nano-chip For Early Cancer Detection
2014-05-19 03:57:21

[ Watch The Video: A New Method For Early Cancer Detection ] ICFO-The Institute of Photonic Sciences Today, the majority of cancers are detected on the macroscopic level, when the tumor is already composed of millions of cancer cells and the disease is starting to advance into a more mature phase. But what if we could diagnose cancer before it took hold- while it was still only affecting a few localized cells? It would be like putting a fire out while it was still just a few sparks...


Word of the Day
mallemaroking
  • Nautical, the visiting and carousing of sailors in the Greenland ships.
This word is apparently from a confusion of two similar Dutch words: 'mallemerok,' a foolish woman, and 'mallemok,' a name for some persons among the crew of a whaling vessel.